Search company, investor...


Founded Year



Acquired | Acquired

Total Raised


About Pepscan

On June 30th, 2022, Pepscan was acquired by Biosynth Carbosynth. Terms of the transaction were not disclosed. Pepscan provides peptide-based products & services offering knowledge of peptides for drug discovery collaborations. At its end-to-end facility in Lelystad, the Netherlands, Pepscan offers a range of patented technologies, phage display capabilities, a lead-optimization array platform, and production facilities for R&D- to GMP-grade peptides, including libraries and neoantigen vaccines. Among its patents is the CLIPS technology, which locks peptides into active conformations. With its epitope mapping service platform, Pepscan also supports biotech companies in developing their antibody pipelines. The underlying protein mimicry platform delivers binding insights, even in cases where other technologies, such as linear, fall short. The company was founded in 2000 and is based in Lelystad, Netherlands.

Headquarters Location

Zuidersluisweg 2

Lelystad, 8243 RC,


+31 320 225300

Missing: Pepscan's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Pepscan's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Pepscan

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Pepscan is included in 1 Expert Collection, including Omics.



1,267 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

Pepscan Patents

Pepscan has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics




Drug discovery, Peptides, Biotechnology, Cyclic peptides, Molecular biology


Application Date


Grant Date



Related Topics

Drug discovery, Peptides, Biotechnology, Cyclic peptides, Molecular biology



Latest Pepscan News

Biosynth Carbosynth, vivitide and Pepscan Rebrand to Biosynth

Sep 7, 2022

Rebranding aligns core Biosynth Group members across Complex Chemical and Peptide Manufacturing Services and Catalog Business. September 07, 2022 06:30 AM Eastern Daylight Time STAAD, Switzerland--( BUSINESS WIRE )--Biosynth Carbosynth, vivitide and Pepscan are pleased to announce today their rebranding to Biosynth to match their parent group and the launch of their site at . Biosynth is a global supplier of critical products and services to the life sciences industry, across the areas of complex chemicals, quality peptides and key biological reagents. In combination with their research product portfolio of more than 600K catalog products across all three areas, Biosynth partners with customers from their first idea to finished product, across research, development and commercial supply of key materials. The new branding evokes the unique combinations that Biosynth offers, where Products meet Services and where Chemistry meets Biology, Biosynth is at “The Edge of Innovation.” Dr. Urs Spitz, CEO and President of Biosynth, said, “We are thrilled to be unveiling our new Biosynth brand today, and to be formally integrating Pepscan and vivitide into the organization. We have long been the go to provider of complex chemicals across carbohydrates, nucleoside, enzyme substrates and beyond, and now have such breadth across peptides. We knew it was the right time to bring us all together so our customers can go to one place for all their needs.” Editor’s notes About Biosynth Biosynth is a supplier of critical materials, securing life sciences supply chains with global research, manufacturing and distribution facilities. Supplying the pharmaceutical, life science and diagnostic sectors; where Chemistry meets Biology, Products meet Services and Innovation meets Quality, Biosynth is at the Edge of Innovation. With an unrivaled research product portfolio of over half a million products and end-to-end manufacturing services, Biosynth’s expertise and capability runs across Complex Chemicals, Peptides and Key Biologics all from one trusted partner. Headquartered in Staad, Switzerland, Biosynth is owned by KKR, Ampersand Capital Partners and management. Find out more about Biosynth at . Other members of the Biosynth group are unaffected by the rebranding at this time. Contacts

Pepscan Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Pepscan Rank

Pepscan Frequently Asked Questions (FAQ)

  • When was Pepscan founded?

    Pepscan was founded in 2000.

  • Where is Pepscan's headquarters?

    Pepscan's headquarters is located at Zuidersluisweg 2, Lelystad.

  • What is Pepscan's latest funding round?

    Pepscan's latest funding round is Acquired.

  • How much did Pepscan raise?

    Pepscan raised a total of $13M.

  • Who are the investors of Pepscan?

    Investors of Pepscan include Biosynth Carbosynth, PPM Oost, Wageningen Business Generator, Lupus Ventures and Flevoland Technofund.

  • Who are Pepscan's competitors?

    Competitors of Pepscan include Scienion, 48Hour Discovery, Zyomyx, Expression Analysis, Third Wave Technologies and 12 more.

Compare Pepscan to Competitors


PolyAn Molecular Surface Engineering: fluorescent encoded polymer microspheres (beads), microarray slides and membranes for Pervaporation and organophilic Nanofiltration

Signature Genomic Laboratories

Signature Genomic Laboratories aims to use microarray technology to help diagnose chromosome abnormal disabilities in children with developmental disabilities


Microarray was formed in July 2000, as a joint venture between Manchester Metropolitan University (MMU) and the The University of Manchester. Microarray also offers contract manufacture and sensor development of low/medium volume screen printed disposable sensors both for academia and industry, development and production.

FlexGen Logo

FlexGen is working towards the commercialization of a fast and flexible custom microarray synthesis instrument for genomic selection in sequencing and other applications.

Oxford Molecular

Oxford Molecular aims to provide computational chemistry and molecular graphics to European and U.S. markets.


Chalex Corporation's precision-made chambered McMaster counting slides are used by researchers, laboratories, nematologists and veterinary practitioners throughout the world. Made of clear durable acrylic for long-lasting use, the company's slides also feature exact volumes thanks to injection-molded accuracy which yield consistent test results compared to other slides with handmade chamber spacers. The quality of these slides make them the standard the world over.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.